BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.

ClinicalTrials.gov ID: NCT02788513

Public ClinicalTrials.gov record NCT02788513. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-centre, Double-blind, Parallel-group, Randomised Controlled Study to Investigate Efficacy and Safety of Orally Administered BI 425809 During a 12-week Treatment Period Compared to Placebo in Patients With Cognitive Impairment Due to Alzheimer's Disease.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study is designed to compare the effects of BI 425809 compared to placebo in patients with cognitive impairment due to Alzheimer's Disease.

Study identification

NCT ID: NCT02788513
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Boehringer Ingelheim; Industry
Enrollment: 611 participants

Conditions and interventions

Conditions

Alzheimer Disease

Interventions

Drug

Eligibility (public fields only)

Age range: 55 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 11, 2016 (Actual)
Primary completion: Sep 12, 2019 (Actual)
Completion: Oct 11, 2019 (Actual)
Last update posted: Nov 6, 2020

2016 – 2019

United States locations

U.S. sites: 17
U.S. states: 9
U.S. cities: 15

Facility	City	State	ZIP	Site status
Axiom Research LLC	Colton	California	92324	—
Alliance for Wellness	Long Beach	California	90807	—
Anderson Clinical Research	Redlands	California	92374	—
CITrials	Santa Ana	California	92705	—
MD Clinical	Hallandale	Florida	33009	—
Galiz Research	Miami	Florida	33016	—
Premier Clinical Research Institute	Miami	Florida	33122	—
Miami Jewish Health System	Miami	Florida	33137	—
Stedman Clinical Trials	Tampa	Florida	33613	—
Bioclinica Research	The Villages	Florida	32162	—
Neuro Trials Research Incorporated	Atlanta	Georgia	30342	—
Millennium Psychiatric Associates LLC	St Louis	Missouri	63132	—
ANI Neurology, PLLC, dba Alzheimer's Memory Center	Charlotte	North Carolina	28270	—
Tulsa Clinical Research, LLC	Tulsa	Oklahoma	74104	—
Northeastern Pennsylvania Memory and Alzheimer Center	Plains	Pennsylvania	18705	—
Roper St. Francis Healthcare	Charleston	South Carolina	29401	—
The Memory Clinic	Bennington	Vermont	05201	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 78 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02788513, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Nov 6, 2020 · Synced Oct 22, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02788513 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →